AU2019286641A1 - Small molecule inhibitors of the JAK family of kinases - Google Patents

Small molecule inhibitors of the JAK family of kinases Download PDF

Info

Publication number
AU2019286641A1
AU2019286641A1 AU2019286641A AU2019286641A AU2019286641A1 AU 2019286641 A1 AU2019286641 A1 AU 2019286641A1 AU 2019286641 A AU2019286641 A AU 2019286641A AU 2019286641 A AU2019286641 A AU 2019286641A AU 2019286641 A1 AU2019286641 A1 AU 2019286641A1
Authority
AU
Australia
Prior art keywords
yielded
compound
suspension
diffractogram
jak
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2019286641A
Other languages
English (en)
Inventor
Philippe Fernandes
Mark S. Tichenor
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceutica NV
Original Assignee
Janssen Pharmaceutica NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=67766195&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU2019286641(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Janssen Pharmaceutica NV filed Critical Janssen Pharmaceutica NV
Publication of AU2019286641A1 publication Critical patent/AU2019286641A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AU2019286641A 2018-06-15 2019-06-14 Small molecule inhibitors of the JAK family of kinases Abandoned AU2019286641A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201862685737P 2018-06-15 2018-06-15
US62/685,737 2018-06-15
US201962846290P 2019-05-10 2019-05-10
US62/846,290 2019-05-10
PCT/IB2019/055005 WO2019239387A1 (en) 2018-06-15 2019-06-14 Small molecule inhibitors of the jak family of kinases

Publications (1)

Publication Number Publication Date
AU2019286641A1 true AU2019286641A1 (en) 2020-12-10

Family

ID=67766195

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2019286641A Abandoned AU2019286641A1 (en) 2018-06-15 2019-06-14 Small molecule inhibitors of the JAK family of kinases

Country Status (23)

Country Link
US (3) US20200017498A1 (cg-RX-API-DMAC7.html)
EP (1) EP3807277A1 (cg-RX-API-DMAC7.html)
JP (1) JP2021528391A (cg-RX-API-DMAC7.html)
KR (1) KR102768284B1 (cg-RX-API-DMAC7.html)
CN (1) CN112313233A (cg-RX-API-DMAC7.html)
AU (1) AU2019286641A1 (cg-RX-API-DMAC7.html)
BR (1) BR112020024744A2 (cg-RX-API-DMAC7.html)
CA (1) CA3101438A1 (cg-RX-API-DMAC7.html)
CL (1) CL2020003227A1 (cg-RX-API-DMAC7.html)
CO (1) CO2020015396A2 (cg-RX-API-DMAC7.html)
CR (1) CR20200603A (cg-RX-API-DMAC7.html)
EC (1) ECSP20080817A (cg-RX-API-DMAC7.html)
IL (1) IL279314A (cg-RX-API-DMAC7.html)
JO (1) JOP20200311A1 (cg-RX-API-DMAC7.html)
MA (1) MA52900A (cg-RX-API-DMAC7.html)
MX (1) MX2020013688A (cg-RX-API-DMAC7.html)
NI (1) NI202000100A (cg-RX-API-DMAC7.html)
PE (1) PE20212113A1 (cg-RX-API-DMAC7.html)
PH (1) PH12020551984A1 (cg-RX-API-DMAC7.html)
SG (1) SG11202011691PA (cg-RX-API-DMAC7.html)
TW (1) TW202016110A (cg-RX-API-DMAC7.html)
UY (1) UY38262A (cg-RX-API-DMAC7.html)
WO (1) WO2019239387A1 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JOP20190144A1 (ar) 2016-12-16 2019-06-16 Janssen Pharmaceutica Nv إيميدازو بيرولو بيريدين كمثبطات لعائلة jak الخاصة بإنزيمات الكيناز
MX2022004474A (es) 2016-12-16 2023-08-15 Janssen Pharmaceutica Nv Inhibidores de moléculas pequeñas de la familia de quinasas jak.
TW202016110A (zh) 2018-06-15 2020-05-01 比利時商健生藥品公司 Jak激酶家族之小分子抑制劑
US12390451B2 (en) 2021-03-11 2025-08-19 Janssen Pharmaceutica Nv Small molecule inhibitor of the JAK family of kinases
CN113292561A (zh) * 2021-05-22 2021-08-24 中国药科大学 一种二吡咯并吡啶结构的化合物、制备方法和医药用途

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6080747A (en) 1999-03-05 2000-06-27 Hughes Institute JAK-3 inhibitors for treating allergic disorders
AR023561A1 (es) 1999-04-23 2002-09-04 Smithkline Beecham Corp Una forma polimorfica del acido maleico de un derivado de tiazolidin-2, 4 diona, una composicion farmaceutica y el uso de dicho polimorfo para lafabricacion de un medicamento
AR033485A1 (es) 2001-09-25 2003-12-26 Otsuka Pharma Co Ltd Sustancia medicinal de aripiprazol de baja higroscopicidad y proceso para la preparacion de la misma
JP2005529933A (ja) 2002-05-31 2005-10-06 シェーリング コーポレイション キサンチンホスホジエステラーゼvインヒビター多形体
GB0319935D0 (en) 2003-08-26 2003-09-24 Cipla Ltd Polymorphs
US7737279B2 (en) 2005-05-10 2010-06-15 Bristol-Myers Squibb Company 1,6-dihydro-1,3,5,6-tetraaza-as-indacene based tricyclic compounds and pharmaceutical compositions comprising same
WO2007005462A1 (en) 2005-07-01 2007-01-11 Wyeth Crystalline forms of 4-[(2,4-dichloro-5-methoxyphenyl)amino]-6-methoxy-7-[3-(4-methyl-1-piperazinyl)propoxy]-3-quinolinecarb-onitrile and methods of preparing the same
JP5071374B2 (ja) 2005-07-14 2012-11-14 アステラス製薬株式会社 ヘテロ環ヤヌスキナーゼ3阻害剤
CN102127078A (zh) 2005-07-14 2011-07-20 安斯泰来制药株式会社 Janus激酶3的杂环类抑制剂
AU2009257602B2 (en) 2008-06-10 2015-10-08 Abbvie Inc. Novel tricyclic compounds
SI2473510T1 (sl) 2009-09-03 2014-10-30 Bristol-Myers Squibb Company Jak2 inhibitorji in njihova uporaba za zdravljenje mieloproliferativnih bolezni in raka
JP2013512282A (ja) * 2009-12-01 2013-04-11 アボット・ラボラトリーズ 新規三環式化合物
EP4782062A2 (en) 2009-12-01 2026-07-29 AbbVie Inc. Novel tricyclic compounds
CN102712640A (zh) 2010-01-12 2012-10-03 弗·哈夫曼-拉罗切有限公司 三环杂环化合物、其组合物和应用方法
CA2789186A1 (en) 2010-02-10 2011-08-18 Genon Biotechnologies Oy Dual activity kinase domains and uses thereof
WO2013007765A1 (en) * 2011-07-13 2013-01-17 F. Hoffmann-La Roche Ag Fused tricyclic compounds for use as inhibitors of janus kinases
GB201212081D0 (en) 2012-07-06 2012-08-22 Kalvista Pharmaceuticals Ltd New polymorph
JP6248948B2 (ja) 2013-02-08 2017-12-20 日産化学工業株式会社 3環性ピロロピリジン化合物及びjak阻害剤
EP2924026A1 (en) 2014-03-28 2015-09-30 Novartis Tiergesundheit AG Aminosulfonylmethylcyclohexanes as JAK inhibitors
JP6561984B2 (ja) 2014-05-14 2019-08-21 日産化学株式会社 3環性化合物及びjak阻害剤
ES2924698T3 (es) 2015-05-28 2022-10-10 Theravance Biopharma R&D Ip Llc Proceso e intermedios para la preparación de compuestos de naftiridina como inhibidores de quinasa JAK
WO2017079639A1 (en) 2015-11-04 2017-05-11 Mayo Foundation For Medical Education And Research Methods and materials for treating autoimmune conditions
JOP20190053A1 (ar) 2016-09-23 2019-03-21 Novartis Ag مركبات أزا إندازول للاستخدام في إصابات الأوتار و/ أو الرباط
UA125824C2 (uk) 2016-10-24 2022-06-15 Астразенека Аб 6,7,8,9-ТЕТРАГІДРО-3H-ПІРАЗОЛО[4,3-f]ІЗОХІНОЛІНОВІ ПОХІДНІ, ЗАСТОСОВНІ В ЛІКУВАННІ РАКУ
US20200077658A1 (en) 2016-12-16 2020-03-12 Basf Se Pesticidal Compounds
JOP20190144A1 (ar) * 2016-12-16 2019-06-16 Janssen Pharmaceutica Nv إيميدازو بيرولو بيريدين كمثبطات لعائلة jak الخاصة بإنزيمات الكيناز
WO2018109607A1 (en) 2016-12-16 2018-06-21 Pfizer Inc. Glp-1 receptor agonists and uses thereof
MX2022004474A (es) 2016-12-16 2023-08-15 Janssen Pharmaceutica Nv Inhibidores de moléculas pequeñas de la familia de quinasas jak.
JP6793836B2 (ja) 2016-12-16 2020-12-02 イーライ リリー アンド カンパニー 変異体idh1およびidh2阻害剤としての7−フェニルエチルアミノ−4h−ピリミド[4,5−d][1,3]オキサジン−2−オン化合物
MX2019006047A (es) 2016-12-16 2019-10-02 Nestle Sa Oligosacaridos para generacion de sabor.
CN110167938B (zh) 2017-01-11 2024-06-14 阿基利昂有限公司 作为Janus激酶抑制剂的新的氨基-咪唑并吡啶衍生物及其医药用途
CR20190379A (es) 2017-01-30 2019-10-21 Astrazeneca Ab Moduladores del receptor de estrógeno
MX2019012431A (es) 2017-04-21 2020-08-03 Ikena Oncology Inc Inhibidores del receptor de hidrocarburos de arilo (ahr) de indol y usos de los mismos.
TW202016110A (zh) 2018-06-15 2020-05-01 比利時商健生藥品公司 Jak激酶家族之小分子抑制劑
US20200338051A1 (en) 2019-04-24 2020-10-29 Janssen Pharmaceutica Nv Non-clinical liquid formulations of pan-jak inhibitor

Also Published As

Publication number Publication date
JP2021528391A (ja) 2021-10-21
US20200165250A1 (en) 2020-05-28
KR20210021342A (ko) 2021-02-25
EP3807277A1 (en) 2021-04-21
PH12020551984A1 (en) 2021-08-02
BR112020024744A2 (pt) 2021-03-23
TW202016110A (zh) 2020-05-01
PE20212113A1 (es) 2021-11-04
UY38262A (es) 2019-12-31
CR20200603A (es) 2021-01-20
WO2019239387A1 (en) 2019-12-19
US11787807B2 (en) 2023-10-17
US11066406B2 (en) 2021-07-20
MX2020013688A (es) 2021-02-26
JOP20200311A1 (ar) 2020-11-30
ECSP20080817A (es) 2021-01-29
CA3101438A1 (en) 2019-12-19
MA52900A (fr) 2021-04-21
US20210340144A1 (en) 2021-11-04
US20200017498A1 (en) 2020-01-16
KR102768284B1 (ko) 2025-02-13
CO2020015396A2 (es) 2021-03-08
CL2020003227A1 (es) 2021-05-14
NI202000100A (es) 2021-06-30
CN112313233A (zh) 2021-02-02
SG11202011691PA (en) 2020-12-30
IL279314A (en) 2021-01-31

Similar Documents

Publication Publication Date Title
AU2022204240B2 (en) Small molecule inhibitors of the JAK family of kinases
US11827638B2 (en) Imidazopyrrolopyridine as inhibitors of the JAK family of kinases
US11787807B2 (en) Small molecule inhibitors of the JAK family of kinases
CA3046965C (en) Small molecule inhibitors of the jak family of kinases
HK40014753B (en) Imidazo[4,5-d]pyrrolo[2,3-b]pyridine compounds as inhibitors of janus kinases
HK40014753A (en) Imidazo[4,5-d]pyrrolo[2,3-b]pyridine compounds as inhibitors of janus kinases
BR112019011968B1 (pt) Inibidores de pequenas moléculas da família jak de quinases

Legal Events

Date Code Title Description
MK4 Application lapsed section 142(2)(d) - no continuation fee paid for the application